<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "http://jats.nlm.nih.gov/publishing/1.0/JATS-journalpublishing1.dtd">
<article article-type="abstract" dtd-version="1.0" xml:lang="en" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">CC</journal-id>
<journal-id journal-id-type="nlm-ta">Cardiol Croat</journal-id>
<journal-title-group>
<journal-title>Cardiologia Croatica</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Cardiol. Croat.</abbrev-journal-title>
</journal-title-group>
<issn pub-type="ppub">1848-543X</issn>
<issn pub-type="epub">1848-5448</issn>
<publisher><publisher-name>Croatian Cardiac Society</publisher-name></publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">CC 2024 19_11-12_470</article-id>
<article-id pub-id-type="doi">10.15836/ccar2024.470</article-id>
<article-categories><subj-group subj-group-type="heading"><subject>Extended Abstract</subject></subj-group>
<subj-group subj-group-type="subheading"><subject>Valvular heart disease</subject></subj-group>
</article-categories>
<title-group>
<article-title>Paradoxical low flow-low gradient aortic stenosis &#x2013; clinical challenges and multimodality imaging in detecting aortic stenosis</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6983-1409</contrib-id><name><surname>Vitlov</surname><given-names>Petra</given-names></name><xref ref-type="corresp" rid="cor1">*</xref></contrib>
<contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3650-3297</contrib-id><name><surname>Bistrovi&#x0107;</surname><given-names>Petra</given-names></name></contrib>
<contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6502-683X</contrib-id><name><surname>Falak</surname><given-names>Hrvoje</given-names></name></contrib>
<contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6931-5404</contrib-id><name><surname>Ivanovi&#x0107; Mihajlovi&#x0107;</surname><given-names>Vanja</given-names></name></contrib>
<contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9912-2179</contrib-id><name><surname>Udovi&#x010D;i&#x0107;</surname><given-names>Mario</given-names></name></contrib>
<contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8298-7974</contrib-id><name><surname>Grizelj</surname><given-names>Danijela</given-names></name></contrib>
<contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6444-2674</contrib-id><name><surname>Manola</surname><given-names>&#x0160;ime</given-names></name></contrib>
<aff id="aff1"><institution>Dubrava University Hospital</institution>, <addr-line>Zagreb</addr-line>, <country country="hr">Croatia</country></aff>
</contrib-group>
<author-notes>
<corresp id="cor1"><label>*</label>ADDRESS FOR CORRESPONDENCE: Petra Vitlov, Klini&#x010D;ka bolnica Dubrava, Avenija Gojka &#x0160;u&#x0161;ka 6, HR-10000 Zagreb, Croatia. / Phone: +385-91-8991-911 / E-mail: <email xlink:href="petra.vitlov@gmail.com">petra.vitlov@gmail.com</email></corresp></author-notes>
<pub-date date-type="pub" publication-format="electronic"><month>11</month><year>2024</year></pub-date>
<pub-date date-type="pub" publication-format="print"><month>11</month><year>2024</year></pub-date>
<volume>19</volume>
<issue>11-12</issue>
<fpage>470</fpage>
<lpage>470</lpage>
<history>
<date date-type="received"><day>13</day><month>10</month><year>2024</year></date>
<date><day>31</day><month>10</month><year>2024</year></date>
</history>
<permissions>
<copyright-statement>Croatian Cardiac Society</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Croatian Cardiac Society</copyright-holder>
</permissions>
<kwd-group kwd-group-type="author"><title>KEYWORDS: </title><kwd>aortic stenosis</kwd><kwd>aortic valve calcium score</kwd><kwd>multimodality imaging</kwd></kwd-group>
</article-meta>
</front>
<body>
<p><bold>Introduction</bold>: Low flow-low gradient aortic stenosis (LFLG AS) with preserved left ventricular ejection fraction (LVEF), also called &#x201C;paradoxical&#x201D; LFLG (PLFLG) is defined as AS with a mean gradient (mean PG) &lt;40 mmHg (or peak velocity &lt;4 m/sec), valve area (AVA) &lt;1.0 cm<sup>2</sup> with preserved LVEF (&gt;50%) but stroke volume index (SVi) &lt;35 ml/m<sup>2</sup>. (<xref ref-type="bibr" rid="r1"><italic>1</italic></xref>, <xref ref-type="bibr" rid="r2"><italic>2</italic></xref>) Even after exclusion of measurement errors and other potential causes of the echocardiographic findings, diagnosing true severe AS in these patients still remains a challenge. Given that prior studies have shown worse prognosis in PLFLG severe AS patients compared to those with moderate AS and true severe AS, it is crucial to establish the correct diagnosis. (<xref ref-type="bibr" rid="r3"><italic>3</italic></xref>)</p>
<p><bold>Case report</bold>: 76-year-old female patient was referred to our institution due to symptoms of stable angina and echocardiographic parameters of severe LFLG AS with preserved LVEF. Coronary angiography revealed a subtotal proximal LAD stenosis. Initially, surgical aortic valve replacement and a LAD-LIMA bypass were planned. However, after revaluation, due to borderline calculated AVA of 1 cm<sup>2</sup>, peak aortic valve velocity 3 m/s, mean PG 21 mmHg, and SVi 32 ml/m<sup>2</sup>, further tests were necessary before potential surgery. After confirming low flow state, AVA of 1.4 cm<sup>2</sup> was measured using transesophageal planimetry. Also, the aortic valve calcium score of 250 was calculated through computed tomography, thus excluding severe AS. Patient underwent percutaneous coronary intervention with successful LAD stenting using provisional technique and will be followed up regularly for AS progression.</p>
<p><bold>Conclusion</bold>: PLFLG AS remains a challenging diagnosis. Even with additional testing, such as dobutamine echocardiography, it is unclear how to optimally distinguish pseudosevere and true severe AS. Transesophageal valve planimetry and quantification of valve calcification may add important information in this context. In any case, severe AS must be carefully confirmed before deciding on intervention.</p>
</body>
<back>
<ref-list>
<title>LITERATURE</title>
<ref id="r1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vahanian</surname><given-names>A</given-names></name><name><surname>Beyersdorf</surname><given-names>F</given-names></name><name><surname>Praz</surname><given-names>F</given-names></name><name><surname>Milojevic</surname><given-names>M</given-names></name><name><surname>Baldus</surname><given-names>S</given-names></name><name><surname>Bauersachs</surname><given-names>J</given-names></name><etal/></person-group> <article-title>2021 ESC/EACTS Guidelines for the management of valvular heart disease.</article-title> <source>Eur Heart J</source>. <year>2022</year> February 12;<volume>43</volume>(<issue>7</issue>):<fpage>561</fpage>&#x2013;<lpage>632</lpage>. <pub-id pub-id-type="doi">10.1093/eurheartj/ehab395</pub-id><pub-id pub-id-type="pmid">34453165</pub-id></mixed-citation></ref>
<ref id="r2"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Orwat</surname><given-names>S</given-names></name><name><surname>Kaleschke</surname><given-names>G</given-names></name><name><surname>Kerckhoff</surname><given-names>G</given-names></name><name><surname>Radke</surname><given-names>R</given-names></name><name><surname>Baumgartner</surname><given-names>H</given-names></name></person-group>. <article-title>Low flow, low gradient severe aortic stenosis: diagnosis, treatment and prognosis.</article-title> <source>EuroIntervention</source>. <year>2013</year> September 10;<volume>9</volume> <supplement>Suppl</supplement>:<fpage>S38</fpage>&#x2013;<lpage>42</lpage>. <pub-id pub-id-type="doi">10.4244/EIJV9SSA8</pub-id><pub-id pub-id-type="pmid">24025956</pub-id></mixed-citation></ref>
<ref id="r3"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clavel</surname><given-names>MA</given-names></name><name><surname>Dumesnil</surname><given-names>JG</given-names></name><name><surname>Capoulade</surname><given-names>R</given-names></name><name><surname>Mathieu</surname><given-names>P</given-names></name><name><surname>S&#x00E9;n&#x00E9;chal</surname><given-names>M</given-names></name><name><surname>Pibarot</surname><given-names>P</given-names></name></person-group>. <article-title>Outcome of patients with aortic stenosis, small valve area, and low-flow, low-gradient despite preserved left ventricular ejection fraction.</article-title> <source>J Am Coll Cardiol</source>. <year>2012</year> October 2;<volume>60</volume>(<issue>14</issue>):<fpage>1259</fpage>&#x2013;<lpage>67</lpage>. <pub-id pub-id-type="doi">10.1016/j.jacc.2011.12.054</pub-id><pub-id pub-id-type="pmid">22657269</pub-id></mixed-citation></ref>
</ref-list>
</back>
</article>
